Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation Therapy

NCT00898430 · clinicaltrials.gov ↗

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Study closed prematurely upon PI's departure

Conditions

Head and Neck Cancer

Interventions

GENETIC: DNA Microarray analysis
GENETIC: MALDI-TOF mass spectrometry
GENETIC: DNA microarray and MALDI-TOF mass spectrometry

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]